Lithium protects against methamphetamine-induced neurotoxicity in PC12 cells via Akt/GSK3β/mTOR pathway

Biochem Biophys Res Commun. 2015 Sep 25;465(3):368-73. doi: 10.1016/j.bbrc.2015.08.005. Epub 2015 Aug 10.

Abstract

Methamphetamine (MA) is neurotoxic, especially in dopaminergic neurons. Long-lasting exposure to MA causes psychosis and increases the risk of Parkinson's disease. Lithium (Li) is a known mood stabilizer and has neuroprotective effects. Previous studies suggest that MA exposure decreases the phosphorylation of Akt/GSK3β pathway in vivo, whereas Li facilitates the phosphorylation of Akt/GSK3β pathway. Moreover, GSK3β and mTOR are implicated in the locomotor sensitization induced by psychostimulants and mTOR plays a critical role in MA induced toxicity. However, the effect of MA on Akt/GSK3β/mTOR pathway has not been fully investigated in vitro. Here, we found that MA exposure significantly dephosphorylated Akt/GSK3β/mTOR pathway in PC12 cells. In addition, Li remarkably attenuated the dephosphorylation effect of MA exposure on Akt/GSK3β/mTOR pathway. Furthermore, Li showed obvious protective effects against MA toxicity and LY294002 (Akt inhibitor) suppressed the protective effects of Li. Together, MA exposure dephosphorylates Akt/GSK3β/mTOR pathway in vitro, while lithium protects against MA-induced neurotoxicity via phosphorylation of Akt/GSK3β/mTOR pathway.

Keywords: Akt; GSK3β; Lithium; Methamphetamine; Neurotoxicity; mTOR.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Survival / drug effects
  • Dose-Response Relationship, Drug
  • Glycogen Synthase Kinase 3 / metabolism*
  • Glycogen Synthase Kinase 3 beta
  • Lithium Chloride / administration & dosage*
  • Methamphetamine / toxicity*
  • Neurons / drug effects
  • Neurons / metabolism*
  • Neurons / pathology
  • Neuroprotective Agents / administration & dosage
  • Neurotoxins / toxicity
  • Oncogene Protein v-akt / metabolism*
  • PC12 Cells
  • Phosphorylation / drug effects
  • Rats
  • Signal Transduction / drug effects
  • TOR Serine-Threonine Kinases / metabolism*

Substances

  • Neuroprotective Agents
  • Neurotoxins
  • Methamphetamine
  • mTOR protein, rat
  • Glycogen Synthase Kinase 3 beta
  • Gsk3b protein, rat
  • Oncogene Protein v-akt
  • TOR Serine-Threonine Kinases
  • Glycogen Synthase Kinase 3
  • Lithium Chloride